Stocks · Health care · Pharmaceutical Preparations

Opus Genetics, Inc.

IRD Clue Score33
United States Fiscal year ends December CIK 0001228627 Results filed 6 Aug 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
George Magrath
3 Nov 2026
Chief Executive Officer
Sell
28,258
$3.90
$110.18K
George Magrath
23 Oct 2026
Chief Executive Officer
Sell
9,591
$3.59
$34.38K
Robert E. Gagnon
23 Oct 2026
Chief Financial Officer
Sold on a plan
14,000
$3.55
$49.65K
Benjamin R Yerxa
23 Oct 2026
President
Sell
25,520
$3.53
$90.13K
Benjamin R Yerxa
23 Oct 2026
President
Sell
7,669
$3.55
$27.24K
Joseph K Schachle
23 Oct 2026
Chief Operating Officer
Sell
4,767
$3.57
$16.99K

What was left out

Form 4 filings counted 5
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 0
Sales at will 5
Transactions with no price 0
Shares from compensation/vesting 0
History held since 8 Jan 2007